This post is from a suggested group
Liquid Biopsy: Revolutionizing Cancer Detection and Monitoring
The landscape of cancer diagnosis and management is evolving rapidly, and liquid biopsy has emerged as a transformative technology in this field. Unlike traditional tissue biopsies, which require invasive procedures to collect tumor samples, liquid biopsy offers a minimally invasive alternative. It analyzes biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes present in body fluids, typically blood, to provide valuable insights into a patient’s condition.
One of the most significant advantages of liquid biopsy is its ability to detect cancer at an early stage. Tumors often release fragments of DNA into the bloodstream well before they become detectable through imaging or physical examination. By identifying these fragments, clinicians can potentially intervene sooner, improving treatment outcomes. This early detection capability is especially important for aggressive cancers, where timely diagnosis can make a critical difference.
Beyond early detection, liquid biopsy…